Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

STATUS

Recruiting
End date

Jun 5, 2026
participants needed

30
sponsor

Oregon Health and Science University

Send

Updated on 19 February 2024

See if I qualify

transcranial magnetic stimulation

dopamine

progressive supranuclear palsy

speech therapy

Summary

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP by increasing functional connectivity between the cerebellum, thalamus, and primary motor cortex.

Details

Condition	Progressive supranuclear palsy, Palsy Supranuclear
Age	40-85 years
Treatment	Repetitive transcranial magnetic stimulation (rTMS)
Clinical Study Identifier	NCT04468932
Sponsor	Oregon Health and Science University
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	probable or possible PSP by the revised MDS PSP Criteria (Hoglinger 2017)
	age 40-85 at time of screening
	ability to understand and cooperate with simple instructions in English
	ability to read at 6th grade reading level in English
	ability to tolerate balance testing with a safety harness
	ability to refrain from other physical and speech therapy programs for the duration for the study
	ability to remain on stable doses of any cholinergic, dopaminergic, serotonergic sedative or NMDA receptor antagonists for the duration of the study
	females of child-bearing age must perform a urine pregnancy test and be on reliable birth control during the course of the study
Exclusion Criteria
	other significant neurological or vestibular disorders
	presence of electrically, magnetically or mechanically activated implants or history of injurious metal exposure in eyes, head, or body

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

transcranial magnetic stimulation

dopamine

progressive supranuclear palsy

speech therapy

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy